On 3-4 February, in Italy, the EHC and Kedrion organised a workshop on Factor X (FX) deficiency, bringing together patient representatives and healthcare providers. Participants engaged in insightful discussions and shared experiences at both regional and national levels.

The EHC European Rare and Inhibitor Network (ERIN) plays a crucial role in raising awareness and improving pathways for diagnosis and access to care for all individuals with extremely rare bleeding disorders.

To learn more about ERIN’s work, visit the dedicated page on the EHC Community website!